LIFE HEALTHCARE GROUP HOLDINGS LIMITED - Dealings in securities by directors and a director of a major subsidiary

Dealings in securities by directors and a director of a major subsidiary

LIFE HEALTHCARE GROUP HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 2003/002733/06)
ISIN: ZAE000145892
Share code: LHC
(“Life Healthcare” or “the Company”)

DEALINGS IN SECURITIES BY DIRECTORS AND A DIRECTOR OF A MAJOR SUBSIDIARY

In compliance with the JSE Limited Listings Requirements, Life Healthcare shareholders are hereby advised of
the following purchases made by the Group Chief Executive Officer and director of the Company, Peter
Warton-Hood, and the Chief Financial Officer – South Africa, Megandra Naidoo who is a director of a major
subsidiary.

In addition, shareholders are referred to the SENS announcement made on 2 April 2020, where the market
was advised of the shares awarded to a director of a major subsidiary and the Chief Executive Officer, South
Africa, Mr Adam Pyle in terms of a bespoke retention share scheme. These shares recently vested, and Mr
Pyle has elected to retain the shares but sell a portion to cover tax and costs associated with the vesting of
the shares.

Below are the details in relation to the respective purchases and sale of shares by the directors:

  Name of director                                            :   Peter Wharton-Hood
  Name of Company                                             :   Life Healthcare Group Holdings
  Nature of transaction                                       :   On market purchase of shares by the director
  Date of transaction                                         :   26 November 2021
  Number of securities                                        :   200 000
  Class of securities                                         :   Ordinary shares
  Total value of transaction                                  :   R4 453 341.09
  Purchase price per share                                    :   R22.27
  Nature of interest                                          :   Direct beneficial
  Clearance obtained                                          :   Yes

  Name of director                                            :   Megandra Naidoo
  Name of Company                                             :   Life Healthcare Group (Pty) Ltd
  Nature of transaction                                       :   On market purchase of shares by the director
  Date of transaction                                         :   29 November 2021
  Number of securities purchased                              :   23 750
  Class of securities                                         :   Ordinary shares
  Total value of transaction                                  :   R545 900.00
  Volume-weighted average purchase price per share            :   R22.99
  Highest purchase price per share                            :   R23.10
  Lowest purchase price per share                             :   R22.79
  Nature of interest                                          :   Direct beneficial

  Clearance obtained                                          :   Yes
  Date of transaction                                         :   30 November 2021
  Number of securities purchased                              :   20 000
  Class of securities                                         :   Ordinary shares
  Total value of transaction                                  :   R468 382.52
  Volume-weighted average of purchase price per share         :   R23.42
  Highest purchase price per share                            :   R23.46
  Lowest purchase price per share                             :   R23.35
  Nature of interest                                          :   Direct beneficial
  Clearance obtained                                          :   Yes

  Name of director                                            :   Adam Pyle
  Name of Company                                             :   Life Healthcare Group Holdings
  Nature of transaction                                       :   On market sale of shares by the director
  Date of transaction                                         :   30 November 2021
  Number of securities                                        :   38 404
  Class of securities                                         :   Ordinary shares
  Total value of transaction                                  :   R898 933.95
  Volume-weighted average of selling price per share          :   R23.41
  Highest selling price per share                             :   R23.43
  Lowest selling price per share                              :   R23.40
  Nature of interest                                          :   Direct beneficial
  Clearance obtained                                          :   Yes

Dunkeld
2 December 2021

Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 02-12-2021 04:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.